Paper Details

  1. Home
  2. Paper Details

Imiquimod for anogenital warts in non-immunocompromised adults.

Author: Angel-MüllerEdith, GaitánHernando G, Grillo-ArdilaCarlos F, LethabyAnne, Ruiz-ParraAriel I, Salazar-DíazLuis C

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Genital warts (AGW) can disappear on their own in about 30% of people, but there's no way to predict which warts will go away. Many treatment options exist, chosen based on doctor and patient preferences. Imiquimod, a medication applied by the patient, may offer advantages over treatments given by a doctor.
Paper Details　
Original Abstract of the Article :
30% of people with anogenital warts (AGW) have spontaneous regression of lesions but there is no way to determine whether a specific lesion will remain. There are a wide range of options available for treating people with AGW and selection is based on clinician's experience, patient preferences and ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD010389.pub2

データ提供：米国国立医学図書館（NLM）

Imiquimod: A New Oasis in the Treatment of Anogenital Warts

Anogenital warts (AGW), like a stubborn patch of desert brush, can be challenging to treat. This study explores the potential of imiquimod, a topical cream, in treating AGW in non-immunocompromised adults. The researchers point out that while a significant percentage of people with AGW experience spontaneous remission, there is no way to predict which lesions will disappear on their own. The study highlights the benefits of patient-applied therapies, like imiquimod, offering an alternative to provider-administered treatments, like a traveler finding a refreshing oasis in a vast desert.

Imiquimod: A New Weapon in the Fight Against AGW

The study offers a promising new approach to the treatment of AGW, like discovering a hidden oasis in the vast desert of treatment options. Imiquimod, a patient-applied topical cream, offers a convenient and effective alternative to provider-administered treatments.

A Oasis in the Desert: Patient-Applied Therapies

The study highlights the importance of patient-applied therapies, like imiquimod, in treating conditions like AGW. It's like discovering a refreshing oasis in the vast desert of treatment options, offering a convenient and effective way for individuals to manage their condition.

Dr. Camel's Conclusion

This research explores the potential of imiquimod as a valuable addition to the arsenal of treatments for AGW. It's like finding a new oasis in the vast desert of treatment options, offering hope and convenience for those affected by this condition.
Date :
  1. Date Completed 2014-12-30
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

25362229

DOI: Digital Object Identifier

10.1002/14651858.CD010389.pub2

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.